Portal de investigación
ADHERENCIA AL TRATAMIENTO ANTIBIÓTICO INHALADO DE LOS PACIENTES CON FIBROSIS QUÍSTICA. ESTUDIO I-ADHERENCIA.
Datos básicos
- Código:
- GYS-COL-2011-01
- Protocolo:
- GYS-COL-2011-01
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[[Translated article]]Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists.
Herranz-Pinto P; (...); Tortajada Goitia B
Practice Guideline. 10.1016/j.ad.2023.07.008. 2023
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Checklist for the pharmaceutical care of patients with interstitial lung disease (CheckEPID): A Delphi-based consensus.
Calvin-Lamas, Marta; (...); Ventayol Bosch, Pere
Article. 10.1016/j.farma.2023.09.004. 2023
2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus.
Martin Conde MT; (...); Morillo-Verdugo, Ramon
Article. 10.1016/j.farma.2023.04.008. 2023
2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus.
Martin, Maria Teresa; (...); Morillo-Verdugo, Ramon
Article. 10.1016/j.farma.2023.01.007. 2023
A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis.
Figueras I; (...); Ortiz de Frutos FJ
Article. 10.2340/actadv.v104.18255. 2024
A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.
Neurohr, Claus; (...); Behr, Juergen
Article. 10.1111/ajt.16858. 2022
Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1007/s40292-021-00476-4. 2021
Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic.
Lopez Sanchez, Piedad; (...); Monte Boquet, Emilio
Article. 10.1016/j.farma.2024.10.001. 2024
Antifibrotics and lung transplantation: A Spanish multicentre case-controlled study
Mora Cuesta, Victor Manuel; (...); Cifrian Martinez, Jose Manuel
Article. 10.1111/resp.14352. 2022
Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection.
Monforte, Victor; (...); Gomez-Olles, Susana
Case Reports. 10.1016/j.arbres.2021.10.002. 2022
Best practices during COVID-19 pandemic in solid organ transplant programs in Spain.
Pascual, Julio; (...); Delgado, Juan F.
Article. 10.1016/j.trre.2023.100749. 2023
BIOSIMILARS IMPACT ON THE RHEUMATOID ARTHRITIS TREATMENT: A COST-EFFECTIVENESS MODEL FROM SPANISH NATIONAL HEALTHCARE SYSTEM PERSPECTIVE
Fernandez Santos, J. M.; (...); Borras Blasco, J.
Meeting Abstract. 2022
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.
Leard LE; (...); Ramos KJ
Practice Guideline. 10.1016/j.healun.2021.07.005. 2021
Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain
Monte-Boquet, Emilio; (...); Sellas, Agusti
Article. 10.1016/j.reuma.2022.12.001. 2023
Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13 , 2980.
Pardo-Sanchez, Jose Miguel; (...); Farràs R
Article. 10.3390/cancers13194825. 2021
COST-EFFECTIVENESS ANALYSIS OF BIOSIMILARS BASED TREATMENT SEQUENCES FOR MODERATE-TO-SEVERE CROHN DISEASE IN SPAIN
Fernandez Santos, J. M.; (...); Merino-Bohorquez, V
Meeting Abstract. 2022
Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country
Lopez-Vilella, R.; (...); Almenar Bonet, L.
Article. 2022
CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN
Lopez-Vilella, R; (...); Almenar-Bonet, L
Meeting Abstract. 2021
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cystic Fibrosis: From Salty Malediction to Possible Cure.
Sole, Amparo, Davies, Jane C., Quintana-Gallego, Esther
Editorial Material. 10.1016/j.arbres.2023.10.007. 2023
Checklist for Pharmaceutical Care of the Patient with interstitial lung disease (CheckEPID): A Delphi-based consensus.
Calvin Lamas M; (...); Ventayol Bosch P
Article. 10.1016/j.farma.2023.06.010. 2023
Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.
Megias-Vericat, J E; (...); Poveda Andres, J L
Letter. 10.1016/j.thromres.2024.109122. 2024
Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation
Boada-Perez, Meritxell; (...); Gomez-Olles, Susana
Article. 10.3389/fimmu.2024.1445553. 2025
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.
Verbinnen I; (...); Helliwell PS
Article. 10.1007/s40744-024-00664-3. 2024
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study
Sarmiento, E; (...); Carbone, J
Article. 10.1016/j.healun.2016.10.004. 2017
Evolving Indications for Heart-Lung Transplant in Spain.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.003. 2022
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease.
Carrasco Hernandez, Laura; (...); Quintana Gallego, Esther
Article. 10.1016/j.arbres.2023.05.017. 2023
Filamentous fungi in the airway of patients with cystic fibrosis: Just spectators?
Vinado, Clara; (...); Sole, Amparo
Article. 10.1016/j.riam.2021.03.005. 2021
Fungal microbiota dynamics and its geographic, age and gender variability in patients with cystic fibrosis.
Martinez-Rodriguez, Sara; (...); Horra C
Article. 10.1016/j.cmi.2022.11.001. 2022
Genomic characterization of MRSA recovered from people with cystic fibrosis during two Spanish multicentre studies (2013 and 2021).
Maruri-Aransolo A; (...); Caballero-Pérez JD
Article. 10.1093/jacamr/dlae160. 2024
Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.
Mondejar-Lopez, Pedro; (...); Sanchez-Solis, Manuel
Article. 10.1016/j.rmed.2022.106736. 2022
Hereditary angioedema in Spain: medical care and patient journey.
Caballero, Teresa; (...); Zamora, Carolina
Article. 10.1186/s13023-024-03182-1. 2024
Hyperkalemia in heart failure patients: current challenges and future prospects
Lopez-Vilella, R; (...); Almenar-Bonet, L
Review. 10.2147/RRCC.S75680. 2016
Impact of Lung Function Decline on Mortality in Lung Transplant Recipients: Long-Term Results From the L-CsA-i Study for the Prevention of Bronchiolitis Obliterans Syndrome.
Kneidinger, Nikolaus; (...); Neurohr, Claus
Article. 10.3389/fmed.2022.897581. 2022
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.
Simarro, Javier; (...); Palanca, Sarai
Article. 10.3390/cancers15061705. 2023
Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists.
Herranz-Pinto P; (...); Tortajada Goitia B
Practice Guideline. 10.1016/j.ad.2023.04.019. 2023
Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation
Pardo-Sanchez, JM; (...); Farras, R
Article. 10.3390/cancers13122980. 2021
Inhaled aztreonam lysine in the management of Pseudomonas aeruginosa in patients with cystic fibrosis: real-life effectiveness.
Jimenez-Lozano, Ines; (...); Alvarez-Fernandez, Antonio
Article. 10.1136/ejhpharm-2023-003937. 2023
Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.
Ibáñez-Martínez E; (...); Pemán J
Case Reports. 10.1016/j.riam.2021.06.002. 2021
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements.
Crespo MM; (...); Budev M
Practice Guideline. 10.1016/j.healun.2021.07.014. 2021
Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey
Marin-Jimenez, I; (...); Monte-Boquet, E
Article. 10.7399/fh.11662. 2021
Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
Marín-Jiménez I; (...); Monte-Boquet E
Article. 10.7399/fh.11662. 2021
Longitudinal transcriptional immune profiles and persistent wheezing in moderate-to-late preterm infants.
Rodriguez-Fernandez R; (...); Ramilo O
Article. 10.1111/pai.14261. 2024
Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.
Bilton, Diana; (...); CLEAR-110 Study Group
Article. 10.1016/j.jcf.2021.05.013. 2021
Multiresistant organisms: bacteria and beyond.
Article. 10.1097/MOT.0000000000000976. 2022
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
Oral Ribavirin for Treatment of Respiratory Syncytial Virus in Lung Transplantation Recipients.
Martin-Cerezuela, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1016/j.transproceed.2021.08.037. 2021
Patient-reported outcome measures in severe asthma: an expert consensus.
Martínez-Moragón E; (...); Sánchez-Cuellar S
Article. 10.1080/02770903.2023.2297372. 2023
Position paper: Models of post-transplant care for individuals with cystic fibrosis.
McKone, Edward; (...); Pilewski, Joseph M.
Article. 10.1016/j.jcf.2023.02.011. 2023
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study.
Monforte V; (...); Gómez-Ollés S
Article. 10.1016/j.arbr.2020.12.012. 2021
Pregnancy and fertility in people with cystic fibrosis following lung transplantation.
Taylor-Cousar JL, Sole A, Jain R
Article. 10.1097/MCP.0000000000001117. 2024
Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Article. 10.3390/biomedicines9050458. 2021
Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure
Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T
Article. 10.1016/j.recesp.2018.07.020. 2018
Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)
Gonzalez-Vilchez, F; (...); Abella-Anton, R
Article. 10.1016/j.rec.2019.09.005. 2019
Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.
González-Vilchez F; (...); Groba Marco MDV
Article. 10.1016/j.rec.2020.06.035. 2020
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
Simarro, Javier; (...); Palanca, Sarai
Article. 10.3390/ijms23158526. 2022
Telematic Interview in Telepharmacy: a comprehensive guide for pharmacotherapeutic follow-up and and informed drug delivery.
Barbadillo-Villanueva S; (...); Monte-Boquet E
Article. 10.1016/j.farma.2024.04.008. 2024
Telematic interview in telepharmacy: consensus document for farmacotherapeutic monitoring and informed drug delivery.
Barbadillo-Villanueva S; (...); Monte-Boquet E
Article. 10.1016/j.farma.2024.01.006. 2024
TELEPROM Psoriasis: Enhancing patient-centered care and health-related quality of life (HRQoL) in moderate-to-severe plaque psoriasis.
Mercadal-Orfila G; (...); Herrera-Pérez S
Article. 10.3389/fmed.2024.1465725. 2024
